the main cellular elements that control hyperexcitability in the brain [8] , and interneuron dysfunction can cause pathological hyperexcitability linked to seizure susceptibility or epilepsy [9, 10] . However, in neurodevelopmental disorders such as autism, it is not well understood how specific interneuron dysfunction may contribute to the pathophysiology of cognitive impairment. The purpose of this review is to critically summarize recent advances that support the relationship between interneuron dysfunction and cognitive impairment in human syndromic autism. Autism is so heterogeneous a disorder that this review has concentrated on defined syndromes with known genetic defects, including fragile X syndrome, Rett syndrome, Angelman syndrome, neurofibromatosis type 1 (NF1), and tuberous sclerosis complex (TSC), with particular reference to the pathophysiological findings of murine experimental models of autism ( table 1 ) .
Fragile X Syndrome
Fragile X syndrome is one of the most well-known diseases caused by a chromosomal mutation leading to mental retardation. Between 21 and 50% of boys with fragile X syndrome are on the autistic spectrum [11] , and 1-6% of the autism population has fragile X syndrome [12] . A milder presentation of autistic symptoms is more common, and the most frequent symptoms tend Cx = Cerebral cortex; Hp = hippocampus; Am = amygdala; Ce = cerebellum; CPu = striatum; ↑ = increased numbers or upregulation; ↓ = decreased numbers or downregulation.
to be social anxiety, extreme shyness, and gaze avoidance [13] . Fragile X syndrome is attributed to transcriptional silencing of the fragile X mental retardation 1 (FMR1) gene and the consequent loss of the gene product of FMR1, i.e. fragile X mental retardation protein (FMRP) [14] . In humans, the silencing of FMR1 is caused by hypermethylation, which occurs when a trinucleotide (CGG) repeat located in the 5 ′ untranslated region of the gene expands to a length of more than 200 repeats. FMRP acts as a translational repressor of specific mRNA at synapses and associates not only with these target mRNA but also with the dendritic, nontranslatable RNA BC1 (a short nontranslatable RNA polymerase III transcript). When FMRP is not present, the loss of translational repression of specific mRNA at synapses could result in the synaptic dysfunction phenotype of fragile X syndrome [15] . This FMRP dysfunction perhaps explains the paucity of mature dendrites seen in an autopsy series of fragile X syndrome [16] . These changes are observed in both excitatory and inhibitory neurotransmission across multiple brain regions, including the amygdala, the cerebral cortex, the hippocampus, and the striatum [17, 18] .
In studies of Fmr1 knockout mouse models of fragile X syndrome, the overactivation of metabotropic glutamate receptor signaling has been reported to be a primary defect in the cerebral cortex and hippocampus [19] . A number of studies have also implicated alterations in the GABA system, including the dramatic decreased expression of GABA receptors [20] . Electrophysiological studies have shown that the local excitation of fast-spiking inhibitory interneurons (perisomatic targeting interneurons) decreases in the neocortex, which could explain the decrease in synchrony in the gamma frequency of the neuronal network [21] . The activation of low-threshold spiking interneurons (dendritic-targeting interneurons), which contribute to the synchronization of neuronal networks over a wide range of frequencies, has also been reported to decrease [22] . This alteration results in a reduced inhibitory output, which in turn alters the synchronization and spike output of excitatory neuronal networks in the neocortex. These investigations indicate that a dysfunction in the inhibitory microcircuit plays a key role in the hyperexcitable neural network in fragile X syndrome. Thus, the cortical networks in fragile X syndrome are hyperexcitable and highly synchronous, which explains the state-dependent network defects related to intellectual disability, the increased incidence of seizures, and sensory integration dysfunctions associated with this syndrome [23, 24] .
The amygdala is a central processing center for information with emotional and social relevance. The amygdala dysfunction in fragile X syndrome is supported by structural and functional MRI studies as well as animal behavioral studies [25] . Fmr1 knockout mice exhibit abnormal social behavior [26] , consistent with the findings observed in humans [23] . In the amygdala of Fmr1 knockout mice, a dramatic reduction in the frequency and amplitude of the phasic inhibitory postsynaptic currents, as well as in the number of inhibitory synapses, was observed [27] . This experiment revealed a significant neuronal hyperexcitability in the principal neurons of the amygdala in Fmr1 knockout mice, which was strikingly successfully treated by pharmacological augmentation of the tonic inhibitory tone using the GABA agonist gaboxadol. Using a combination of electrophysiological and genetic approaches, the development of both presynaptic and postsynaptic components of inhibitory neurotransmission in the FXS amygdala is also dramatically altered during critical stages of neuronal circuit formation [28] . These investigations provide important evidence for the development of therapeutic strategies for the treatment of amygdala-based symptoms in fragile X syndrome.
Rett Syndrome
Rett syndrome is a complex and severe X-linked progressive neurological disorder leading to intellectual disability, psychomotor impairment, and autistic behavior that primarily manifests in girls during childhood after an apparently normal early development [29] . More than 95% of Rett syndrome cases are associated with mutations in the genes encoding a transcription repressor, i.e. methyl-CpG-binding protein 2 (MeCP2), which binds methylated DNA and regulates chromatin remodeling and gene expression [30] . MeCP2 is found in a wide variety of tissues, but it appears to be most abundant in the brain [31] . During embryogenesis, the neuronal MeCP2 level is relatively low; however, it progressively increases during the postnatal period, thus suggesting that MeCP2 plays a pivotal role in neuronal maturation throughout the central nervous system [32] .
Mecp2 -null mutant mice appear developmentally normal up to 6 weeks after birth; however, after this period, the mice develop neurologic symptoms, including tremors, motor impairment, hypoactivity, seizures, kyphosis, and the classic forearm movements associated with human Rett syndrome [31] . Studies in Mecp2 knockout mice have indicated that the lack of Mecp2 induces a shift in homeostatic balance between excitation and inhibition in favor of inhibition. For instance, Mecp2 knockout neurons have lower excitatory postsynaptic currents (EPSC) both in culture and in murine models [33] . Whole-cell patch clamp recordings of layer V pyramidal neurons in the primary somatosensory cortex reveal a reduction of both spontaneous EPSC and spontaneous action potential firing [34] . Stronger innervation of the pyramidal neurons by parvalbumin-expressing GABAergic interneurons causes a reduction in the network activity in the visual cortex [35] . These imbalances in favor of inhibition may be responsible for the functional hypoactivity in the cerebral cortex and resultant cognitive and motor dysfunctions observed in Rett syndrome. Contrary to the neocortical circuit, hippocampal hyperactivity and the high frequency of spontaneous multiunit spikes in CA3 are observed, suggesting an impaired excitation/inhibition balance in the CA3 pyramidal neurons, thus leading to a hyperactive hippocampal network [36] . These hippocampal hyperactivities are suggested to contribute to the limbic seizures seen in patients with Rett syndrome.
Recent studies on Mecp2 mutant mice have reported developmental alterations specific to GABAergic interneurons. GABAergic interneurons contain significantly higher levels of MeCP2 protein as compared to nonGABAergic cells [37] . MeCP2-deficient GABAergic neurons show significant deficits in their presynaptic function and GABA immunoreactivity [37] . These results highlight the critical role of Mecp2 in GABA synthesis in GABA-releasing neurons. Mecp2 deletion also results in a reduction in the soma size of 3 major classes of cortical interneurons (i.e. calretinin-, parvalbumin-, and somatostatin-positive cells) and induces an imbalance of the density of the distribution of these interneurons [38] . The loss of the Mecp2 function strongly interferes with the correct establishment of the neocortical inhibitory system, producing effects that are specific to different interneuron subtypes [38] . A role for MECP2 in inhibitory cell function is also indicated by the observation that Mecp2 mutants reared in an enriched environment do not show an environmental enrichment-induced reduction of the inhibitory synaptic density in the cortex typical of wildtype mice [39] . In contrast, the lack of Mecp2 did not prevent the environmental enrichment effects on the excitatory synaptic contacts. These results indicate that MECP2 is required for the structural plasticity of cortical GABAergic interneurons. On the other hand, nonhuman primates provide powerful experimental models to study human development and disease because of their genetic and physiological similarities to humans. Recent advances in gene editing technology have led to the successful generation of a transgenic monkey model of Rett syndrome by TALEN-mediated mutagenesis of MECP2 [40] .
Prader-Willi Syndrome and Angelman Syndrome
Prader-Willi syndrome and Angelman syndrome are the prototypical disorders of aberrations of imprinted genes [41] .
have also been found in some patients with Angelman syndrome [42] . This gene is imprinted in the brain [43] and it is the gene responsible for the Angelman syndrome phenotype. Prader-Willi syndrome is characterized by hypotonia and feeding difficulties in early life, hyperphagia and obesity later, a short stature, hypogonadism, and acromicria. Behavioral problems are common and psychomotor development is mildly affected. Angelman syndrome is characterized by severe mental retardation, absent speech, autistic behavior, an inappropriate happy demeanor, gate ataxia, epilepsy, and dysmorphic features.
UBE3A encodes an E3 ubiquitin ligase that, in the brain, is expressed primarily from the maternal allele as a result of neuron-specific imprinting [43] . Ube3a has been demonstrated to play a crucial role in regulation of synaptic function. The loss of Ube3a function in an Angelman syndrome murine model leads to a defect in experience-dependent synaptic plasticity [44, 45] , which is closely associated with many features of Angelman syndrome, including learning and memory impairment and motor dysfunction [46] . The loss of maternally inherited Ube3a results in a decreased excitatory synaptic drive onto neocortical pyramidal neurons, which appears to be at odds with the enhanced seizure susceptibility; however, the inhibitory drive onto the pyramidal neurons is even more severely decreased. This inhibitory deficit follows the loss of excitatory inputs and appears to arise from defective presynaptic vesicle cycling in multiple interneuron populations [47] . These investigations indicate that Ube3a loss results in more severe inhibitory deficits at the cellular and circuit levels and may contribute to the seizure susceptibility in Angelman syndrome. Ube3a also acts as a transcriptional coactivator for steroid hormone receptors [48] . Defective glucocorticoid receptor signaling in Ube3a knockout mice could lead to the downregulation of parvalbumin-positive interneurons in the hippocampus and the basolateral amygdala from the early postnatal period [49] . This finding is closely associated with the emergence of anxiety and other behavioral deficits in Angelman syndrome, because parvalbumin-positive interneurons are essential for hippocampal longterm potentiation and contextual fear conditioning [50] .
Neurofibromatosis Type 1
NF1 is transmitted as an autosomal dominant trait and it is notable for its great variability of expression. Approximately 50% of such patients have a learning disability, with no specific pattern unique to those with NF1 [51] . Both verbal and nonverbal disabilities occur, as well as attention deficit disorder [52] . Fewer than 10% have mental retardation [53] , and seizures occur in approximately 6-10% of all such patients [54] . The NF1 (neurofibromin 1) gene is located at 17q11.2 and encodes neurofibromin, which is expressed in multiple cell types but is highly expressed in Schwann cells, oligodendrocytes, and neurons [55] . Neurofibromin includes a functional GTPase-activating protein (GAP) domain that regulates the conversion of Ras-guanosine triphosphate (GTP) to Ras-guanosine diphosphate (GDP) [56] . Ras is a membrane-bound intracellular signaling molecule that is activated by complexing with GTP upon ligand binding to a membrane receptor tyrosine kinase. GAP regulates this process by stimulating the GTPase activity that is intrinsic to Ras [57] .
An important function of neurofibromin is regulation of the activity of the oncogene RAS. Neurofibromin is also thought to modulate Ras/extracellular signal-regulated kinase (ERK) signaling, long-term potentiation (LTP), and learning in mice [58] . LTP is a stable, long-lasting change in synaptic strength widely believed to be a key cellular mechanism for learning and memory that is dependent on Ras function [59] . It has been shown that the learning deficits of mice carrying a heterozygous null mutation of Nf1 can be rescued by genetic and pharmacological manipulations which decrease Ras function. In addition, this murine model has increased GABA-mediated inhibition and specific deficits in LTP, both of which can be reversed by decreasing Ras function [58] . These investigations indicate that the learning deficits associated with NF1 may be caused by excessive Ras activity, which leads to impairments in LTP caused by increased GABA-mediated inhibition.
The overactive ERK signaling in hippocampal interneurons causes excessive GABA release, which is associated with memory impairment [60] . Neurofibromin modulates ERK/synapsin1-dependent GABA release, which in turn modulates hippocampal LTP and learning, which can be reversed by pharmacological downregulation of ERK signaling [61] . Ras-dependent increases in GABA release are also found in the medial prefrontal cortex and striatum in Nf1 heterozygous null mutants, suggesting that neurofibromin is an important molecular regulator of the interneuron activity in the prefrontal cortex and striatum, brain regions that are critical for working memory performance [62] . These reports demonstrate that the excess GABA release in multiple brain regions is closely associated with reduced synaptic strengthening and the resultant learning deficits or working memory impairment in NF1.
Tuberous Sclerosis Complex
TSC is a disorder of autosomal dominant inheritance that affects multiple organ systems, resulting in manifold clinical expressions. TSC is caused by heterozygous lossof-function mutations of either the TSC1 or the TSC2 gene, which encode the protein hamartin or tuberin, respectively. Hamartin and tuberin form a complex that inhibits the mammalian target of rapamycin complex 1 (mTORC1), a kinase that controls translation and cell growth [63] . The mTORC1 kinase is inhibited by the GTPase-activating domain of tuberin on the Ras-like protein Rheb [64] . Therefore, the loss of function of TSC1 or TSC2 leads to the increased activity of mTORC1 [65] . The mTOR kinase complex is the central component of a cell growth pathway that responds to changes in nutrients, energy balance, and extracellular signals to control cellular processes [66] . Epilepsy is the most common presenting symptom in TSC. TSC is also associated with a wide range of cognitive and behavioral manifestations. Approximately 50% of all individuals with TSC have a normal intelligence, whereas the other half all have some degree of cognitive impairment ranging from mild learning disabilities to severe mental retardation. Autistic spectrum disorders affect up to 50% of individuals with TSC [67] , and attention-deficit/hyperactivity and related disorders also are common, affecting approximately 50% of patients [68] . The high incidence of both epilepsy and autism in patients with TSC and the dramatic response of infantile spasms to a GABA-potentiating agent, i.e. vigabatrin, lead to the hypothesis that patients with TSC have an altered GABAergic interneuron function.
Murine models of TSC exhibit behavioral changes that parallel the human disease phenotypes including seizures, decreased social interaction, altered vocalizations, and deficits in learning and memory [69] . In conditional knockout mice with selective deletion of the Tsc1 gene in GABAergic interneuron progenitor cells, cortical and hippocampal GABAergic interneurons show increased mTORC1 signaling. The total numbers of GABAergic cells are reduced in the cortex, and ectopic clusters of cells with increased mTORC1 signaling are also seen. These findings support the hypothesis that the Tsc1 gene is involved in GABAergic interneuron development, suggesting that inhibitory cortical neurons may contribute to the pathogenesis of epilepsy and possibly autism in patients with TSC [70] . The hippocampus is a region of the brain important for learning and memory that can be involved in the generation of temporal lobe seizures [71] . The genetic deletion of Tsc1 in murine hippocampal neurons results in a deficit in inhibitory synaptic function manifested by the decreased amplitude of spontaneous miniature inhibitory currents, reduced evoked inhibitory currents, and reduced synaptic inhibitory potentials. These findings likely result from a primary imbalance of excitation and inhibition due to the reduced inhibition on Tsc1 knockout pyramidal neurons [72] . Thus, the excitation/ inhibition imbalance resulting from dysregulated TSC/ mTOR signaling may contribute to neurological dysfunction, including epilepsy and autistic disorders in TSC.
The neurological basis of autism has been thought to lie in multiple noncortical/subcortical regions in addition to the cortex; however, recent evidence suggests that the cerebellum may also be an important determinant in autism [73] . The cerebellum is well known to coordinate motor function; however, it also plays important roles in higher-order cognitive functions [74] . The cerebellum communicates with the cerebral cortex via the inhibitory GABAergic axons of Purkinje cells that project to the deep cerebellar nuclei [75] . The deep cerebellar nuclei then send projections to the thalamus and cerebral cortex [76] . In autism patients, the cerebellar abnormalities observed by brain MRI or autopsy studies include Purkinje cell loss, general cerebellar hypoplasia, vermal hypoplasia or hyperplasia, reduced gray matter, and GABAergic neuronal dysfunction [77, 78] . The murine TSC model with Purkinje cell-specific Tsc2 loss exhibits progressive Purkinje cell degeneration and autistic-like deficits, and behavioral deficits are prevented with an mTOR inhibitor, i.e. rapamycin [79] . This study suggests that Purkinje cells play an important role in TSC-associated autism and provides a murine model of a Tsc2 mutation in which to study the relationship between the cerebellum and au- Fig. 1 . Illustrative summary of the inhibitory dysfunction in multiple brain regions in 5 genetic syndromes associated with autism. Fragile X syndrome, Angelman syndrome, and TSC revealed mainly downregulation of inhibitory neuronal function; however, NF1 showed primarily upregulation in the GABA-mediated inhibitory system. In Rett syndrome, GABAergic presynaptic function is mainly downregulated; however, a stronger innervation of the pyramidal neurons by parvalbumin-expressing interneurons has also been reported, suggesting the presence of both dysregulation mechanisms in inhibitory function.
tism. Both heterozygous and homozygous loss of Tsc1 in murine cerebellar Purkinje cells also results in autisticlike behaviors, including abnormal social interaction, repetitive behavior, and vocalizations, in addition to decreased Purkinje cell excitability. The pathological and behavioral deficits are also prevented by rapamycin treatment. These studies demonstrate the novel role of TSC in Purkinje cell function and define a molecular basis for a cerebellar contribution to cognitive disorders, such as autism [80] .
Conclusions and Perspectives
Alterations to GABAergic circuits during the development of syndromic autism include a wide variety of neurobiological dysfunctions and do not simply involve the loss or gain of a given type of inhibitory mechanism. The characteristics of interneuron dysfunction in each murine model of autism differ for each syndrome ( fig. 1 ), and these diversities may be due to differences in genetic backgrounds or other currently unknown variances. Epilepsy and autism exhibit a similar neurobiological dysfunction, inducing an excitatory/inhibitory imbalance, and interneurons play a crucial role at the crossroads of these disorders. Future studies should give us a greater understanding of the involvement of different classes of GABAergic interneurons in the relationship between the precise pathophysiological mechanisms and corresponding clinical phenotypes in autism. The identification of susceptibility genes is becoming easier as a result of recent developments in molecular genetics. Further comprehensive research into the molecular mechanisms of interneuron dysfunction in autism is necessary to aid in the development of disease-specific targeted therapies as well as epilepsy treatment.
